Centogene

About Centogene

Centogene, founded in 2006, is a biotechnology company that has established itself as a significant player in the field of genetic diagnostics for rare hereditary diseases. The company's headquarters are in Rostock, Germany, and it has expanded its operations globally, with a notable presence in Cambridge, Massachusetts, and Berlin, Germany.

The company's business model is centered around its proprietary CENTOGENE Biodatabank, one of the world's largest repositories of genetic information from patients with rare diseases. This extensive database is the engine that powers the company's diagnostic services and pharmaceutical solutions. Centogene offers a range of services, including genetic testing and analysis, to help in the early and accurate diagnosis of rare diseases. One of its practical solutions is the CentoCard, a dried blood spot collection kit that simplifies the process of sample collection and transportation.

Centogene serves a diverse clientele that includes individual patients, physicians, and pharmaceutical companies. For pharmaceutical partners, the company provides support for clinical trials by identifying patient populations and developing companion diagnostics. This dual approach of providing diagnostic services and collaborating with the pharmaceutical industry allows Centogene to generate revenue from multiple streams. The company's focus on rare diseases addresses a critical unmet need in the healthcare market, as these conditions are often difficult to diagnose and treat.